SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: E'Lane who wrote (8132)5/18/1998 7:23:00 PM
From: Robert D  Read Replies (1) of 23519
 
><To: mkilloran (8129 )
From: E'Lane
Monday, May 18 1998 1:15PM ET
Reply # of 8140

Monday May 18, 12:46 pm Eastern Time

India Orchid claims new of making Viagra

MADRAS, India, May 18 (Reuters) - India's Orchid Chemicals
and Pharmaceuticals Ltd has developed a new process to make
sildenafil citrate, the active molecule in Pfizer Inc's (PFE - news)
anti-impotence drug Viagra, a company spokesman said on
Monday.

''We have indeed made an application to the Drug Controller of
India seeking permission to manufacture sildenafil citrate...which
we have synthesised by a different process,'' the spokesman told
Reuters.

Any ideas on the validity of the following scenario?

Sidenafil citrate (Viagra) black market soars at 15$ a pill. Some countries even permit semi-legal OTC selling. What happens to PFE ??? And VVUS?

Bob
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext